MARKER THERAPEUTICS, INC. Accretion of Discount (Deprecated 2016-01-31)
MARKER THERAPEUTICS, INC. (MRKR) reported Accretion of Discount (Deprecated 2016-01-31) of $492.30 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Notes
us-gaap:AccretionOfDiscount · last filed 2015-04-15
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2014-06-30 was $8.66K.
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for the quarter ending 2014-03-31 was -$483.64K.
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for fiscal 2014 was $492.30K, a 55.68% decline from fiscal 2013.
- MARKER THERAPEUTICS, INC. accretion of discount (deprecated 2016-01-31) for fiscal 2013 was $1.11M.
| Period end | Accretion of Discount (Deprecated 2016-01-31) 3 month | Accretion of Discount (Deprecated 2016-01-31) 6 month | Accretion of Discount (Deprecated 2016-01-31) 9 month | Accretion of Discount (Deprecated 2016-01-31) 12 month | Accretion of Discount (Deprecated 2016-01-31) 173 month | Accretion of Discount (Deprecated 2016-01-31) 179 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $8.66K derived: sum of 3 quarters · filed 2015-04-15 | $492.30K 10-K · filed 2015-04-15 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $8.66K derived: sum of 2 quarters · filed 2014-11-19 | $492.30K 10-Q · filed 2014-11-19 | -$298.41K derived: sum of 4 quarters · filed 2015-04-15 | ||
| 2014-06-30 | $8.66K 10-Q · filed 2014-08-18 | $492.30K 10-Q · filed 2014-08-18 | -$298.41K derived: sum of 3 quarters · filed 2015-04-15 | $348.36K derived: sum of 4 quarters · filed 2015-04-15 | $1.60M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | -$483.64K 10-Q/A · filed 2014-05-21 | -$307.07K derived: sum of 2 quarters · filed 2015-04-15 | $339.70K derived: sum of 3 quarters · filed 2015-04-15 | |||
| 2013-12-31 | $176.57K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $823.34K derived: sum of 2 quarters · filed 2015-04-15 | $1.11M 10-K · filed 2015-04-15 | -$1.59M 10-Q/A · filed 2014-05-21 | ||
| 2013-09-30 | $646.76K 10-Q · filed 2014-11-19 | $934.26K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |